Biomet Hip Replacement Lawsuits: Bernstein Liebhard LLP Comments on Ongoing Biomet M2a Magnum Hip Replacement Studies

Share Article

The Firm is representing clients in Biomet hip lawsuits who suffered hip implant failure, metallosis and other complications allegedly due to the Biomet M2a Magnum Hip Replacement.

Free Case Review
We continue to hear from patients who have allegedly suffered serious complications due to metal-on-metal hip implants, and are representing a number of clients in Biomet hip lawsuits involving the M2a Magnum hip.

As Biomet hip replacement lawsuit claims continue to move forward, the nationwide law firm of Bernstein Liebhard LLP notes that Biomet Inc. is conducting two studies to assess the safety of metal-on-metal hips, including the Biomet M2a Magnum Hip Replacement System. According to a notice posted November 6, 2012 on clinicaltrials.gov, the company is currently enrolling participants in an observational study investigating adverse local tissue reactions in recipients of metal-on-metal hip implants. The study, which is being conducted in compliance with the U.S. Food & Drug Administration’s (FDA) 2011 post-market surveillance order directing metal-on-metal hip replacement manufacturers to conduct safety studies of their products, is expected to be completed in December 2014.*

According to a second notice posted on clinicaltrials.gov that was updated on March 6th, Biomet has been conducting a study in Japan since 2009, the purpose of which is to investigate metal ion release and renal function in M2a Magnum hip patients. The study, which is no longer recruiting participants, is expected to be completed by December 2021, though final data collection for the study’s primary outcome measure is expected to conclude this December.**

“We continue to hear from patients who have allegedly suffered serious complications due to metal-on-metal hip implants, and are representing a number of clients in Biomet hip lawsuits involving the M2a Magnum hip. Post-market surveillance data is desperately needed to fully understand the risks associated with these devices,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free Biomet hip replacement lawsuit evaluations to individuals allegedly injured by the Biomet M2a hip.

Biomet Hip Lawsuits
Dozens of Biomet hip replacement lawsuits are currently pending in a multidistrict litigation underway in U.S. District Court, Northern District of Indiana. All of the lawsuits filed in the proceeding allege the metal-on-metal design of the Biomet M2a Magnum can generate high levels of metal ions, leading to metallosis in the surrounding tissue and early failure of the device. Bernstein Liebhard LLP is actively filing Biomet hip lawsuits in this litigation. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)

The FDA is continuing to investigate the safety of metal-on-metal hip implant devices like the Biomet M2a Magnum hip. According to a communication issued by the agency on January 17th, the FDA has proposed an order requiring manufacturers of metal-on-metal total hip replacement systems to submit premarket approval (PMA) applications, which would make them ineligible for 510(k) clearance. This process allowed all-metal hips, like the Biomet M2a Magnum, to come to market without first undergoing human clinical trials. The FDA has also recommended that doctors consider metal ion testing for all-metal hip replacement patients who are experiencing symptoms of a failing implant, including pain, swelling, loosening of the implant, or change in the ability to walk.***

Victims of metal-on-metal hip implant side effects allegedly associated with the Biomet M2a hip, including metallosis and premature device failure, may be entitled to compensation for medical bills, lost wages, and pain and suffering. A wealth of information about Biomet hip lawsuits is available at Bernstein Liebhard’s website. For additional information, please contact one of our attorneys today by calling 800-511-5092.

*clinicaltrials.gov/ct2/show/NCT01750606?term=NCT01750606&rank=1
**clinicaltrials.gov/ct2/show/NCT01010763?term=Biomet+M2a+Japan&rank=1
**fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website